Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sysmex Signs Agreement with Labcorp for Hematology System

By LabMedica International staff writers
Posted on 27 Sep 2010
Sysmex America, Inc., (Mundelein, Illinois, USA) have signed a five year agreement with Laboratory Corporation of America (LabCorp; Burlington, NC, USA) to provide fully automated hematology systems. More...


Sysmex America, Inc., is a leading medical diagnostic instrument manufacturer and information systems developer, has supplied LabCorp with hematology systems for their primary testing laboratories. Implementation of the systems has been completed.

The hematology systems purchased by LabCorp include Sysmex HST- Hematology Automation Systems comprised of XE-Series Automated Hematology Analyzers, Sysmex SP-1000 Automated Slidemaker/Stainers and Sysmex-distributed CellaVision DM96 Automated Digital Cell Morphology Systems. Sysmex WAM Decision Support Software for the Clinical Laboratory will bring rules-based intelligence to these automation systems by consolidating data from these multiple instruments and performing expert rules-based functions and results management.

The HST-N systems are linked to the AutoSorter II by Motoman, Inc., (West Carrollton, OH, USA). The HST-N systems will also utilize Sysmex's RU-10 Reagent Production System, specifically designed for the Commercial Reference Laboratory, which prepares some of the required analyzer reagents on site, on demand, to help balance inventory and reduce storage space requirements.

John Kershaw, president and CEO of Sysmex America, Inc., said, "We are honored to serve as LabCorp's strategic business partner in its endeavor to provide a new 'intelligent' diagnostic service offering. We trust our innovative automated solutions will provide an unparalleled level of optimization that streamlines operations while providing quality, connectivity and an enhanced service offering."

Related Links:
Sysmex America, Inc
LabCorp
Motoman, Inc



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.